Menu

Coriell Institute CEO Dies

Michael Christman oversaw the organization’s well-known biobank and pioneered a personalized medicine initiative.

Jan 4, 2018
Kerry Grens

CORIELL INSTITUTE FOR MEDICAL RESEARCHThe president and CEO of the Coriell Institute for Medical Research in New Jersey, Michael Christman, died unexpectedly last month (December 25). He was 58.

Christman had founded the Genetics and Genomics department at Boston University in 2001. At Coriell, he had managed a famous biobank that included a diverse collection of induced pluripotent stem cells and launched a personalized medicine project that has recruited thousands of volunteers to share their health and genetic information and receive information about disease risks in return.

“The importance of Dr. Christman’s impact not only on the Coriell Institute, but personalized medicine as a whole cannot be overstated,” Robert Kiep, III, the chairman of the Coriell Institute Board of Trustees, says in a statement. “It was his initiative that got this project off the ground and his guidance that turned it into the unequivocal success that it is today. His death is a terrible loss for us all.”

A North Carolina native, Christman earned a chemistry degree from the University of North Carolina, then a PhD in biochemistry from the University of California, Berkeley. He held a faculty position at the University of California, San Francisco, before his time at Boston University.

According to an obituary on philly.com, Christman’s work at Boston University included a genetics project using data from the Framingham Heart Study to hunt for variants related to obesity.

In 2007, Christman joined the Coriell Institute and sprearheaded the personalized medicine initiative. “The goal is to see information obtained from the human genome project [that will] start to influence clinical medical practice,” Christman told The Scientist in 2008. “We want to build a bridge from information that we now have about genomics from scientific research, and have that information actually change medical decision-making by doctors.”

At the time of his death, Christman and his two children had been visiting family in North Carolina for the holidays. “He went to bed about 9 p.m. on Christmas Eve. He wasn’t feeling well,” his father, Russell Christman, tells philly.com. “We guess it was his heart.”

In addition to his father, Christman is survived by his 16-year-old twins, Max and Emma, two brothers, his stepmother, and his ex-wife.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.